leptin (LEP) gene expression regulatory elements

The modulation of leptin gene expression encompasses the complex regulatory networks that control the transcription and translation of the leptin (LEP) gene, which is almost exclusively expressed in adipocytes. Key regulatory elements include distant and proximal enhancers (e.g., LE1 and LE2), non-coding RNAs such as lncOb, and transcription factors like FOSL2, as well as epigenetic modifications (e.g., DNA methylation of the promoter). Leptin gene expression is tightly linked to body fat content and is influenced by factors such as fasting/feeding, hormones (insulin, glucocorticoids), sympathetic nervous system activity, and non-coding RNAs. Dysregulation of leptin gene expression is implicated in obesity and metabolic diseases. While therapeutic strategies may aim to indirectly modulate this pathway (e.g., by affecting LEP transcription or secretion), "leptin gene expression modulation" is not itself a canonical molecular target like a receptor or enzyme. If the intent is to target the leptin protein or its receptor, those should be separately specified as "leptin" or "leptin receptor (LEPR)." Caveat: "Leptin gene expression modulation" should not be considered a canonical druggable target, but rather a biological process; attempts to list it otherwise may result in ambiguity or non-standard nomenclature.

Other names

leptin gene regulationregulation of LEP expressionleptin enhancer elementsLE1LE2lncOb (lncRNA)

transcriptional activation or repression (via enhancer or promoter activity), epigenetic modification, non-coding RNA-mediated regulation